Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chantal Thys

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Mini Reviews in Medicinal Chemistry|June 22, 2006
Mechanisms of action and targets for actual and future antiplatelet drugsKathleen Freson, Chantal Thys, Christine Wittevrongel, et al.
European Journal of Pediatrics|July 11, 2007
What's new in using platelet research? To unravel thrombopathies and other human disordersKathleen Freson, Veerle Labarque, Chantal Thys, et al.
Blood|October 24, 2002
Shielding the front-strand beta 3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein IbalphaArnaud Bonnefoy, Hiroshi Yamamoto, Chantal Thys, et al.
Human Genetics|December 17, 2002
Molecular cloning and characterization of the GATA1 cofactor human FOG1 and assessment of its binding to GATA1 proteins carrying D218 substitutionsKathleen Freson, Chantal Thys, Christine Wittewrongel, et al.
Human Molecular Genetics|October 11, 2002
Pseudohypoparathyroidism type Ib with disturbed imprinting in the GNAS1 cluster and Gsalpha deficiency in plateletsKathleen Freson, Chantal Thys, Christine Wittevrongel, et al.
Platelets|June 18, 2019
De novo variant in tyrosine kinase SRC causes thrombocytopenia: case report of a second familyLore De Kock, Chantal Thys, Kate Downes, et al.
Human Molecular Genetics|January 26, 2002
Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivationKathleen Freson, Gert Matthijs, Chantal Thys, et al.
Hemasphere|September 29, 2025
Transcriptome profiling of megakaryocytes and platelets: Application to <i>GP9</i>- and <i>IKZF5</i>-related thrombocytopeniaKoenraad De Wispelaere, Fabienne Ver Donck, Kato Ramaekers, et al.
Haematologica|January 14, 2017
The transcription factor GATA1 regulates NBEAL2 expression through a long-distance enhancerAnouck Wijgaerts, Christine Wittevrongel, Chantal Thys, et al.
Nature Medicine|May 31, 2024
Mutations in the U4 snRNA gene RNU4-2 cause one of the most prevalent monogenic neurodevelopmental disordersDaniel Greene, Chantal Thys, Ian R Berry, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Mini Reviews in Medicinal Chemistry|June 22, 2006
Mechanisms of action and targets for actual and future antiplatelet drugsKathleen Freson, Chantal Thys, Christine Wittevrongel, et al.
European Journal of Pediatrics|July 11, 2007
What's new in using platelet research? To unravel thrombopathies and other human disordersKathleen Freson, Veerle Labarque, Chantal Thys, et al.
Blood|October 24, 2002
Shielding the front-strand beta 3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein IbalphaArnaud Bonnefoy, Hiroshi Yamamoto, Chantal Thys, et al.
Human Genetics|December 17, 2002
Molecular cloning and characterization of the GATA1 cofactor human FOG1 and assessment of its binding to GATA1 proteins carrying D218 substitutionsKathleen Freson, Chantal Thys, Christine Wittewrongel, et al.
Human Molecular Genetics|October 11, 2002
Pseudohypoparathyroidism type Ib with disturbed imprinting in the GNAS1 cluster and Gsalpha deficiency in plateletsKathleen Freson, Chantal Thys, Christine Wittevrongel, et al.
Platelets|June 18, 2019
De novo variant in tyrosine kinase SRC causes thrombocytopenia: case report of a second familyLore De Kock, Chantal Thys, Kate Downes, et al.
Human Molecular Genetics|January 26, 2002
Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivationKathleen Freson, Gert Matthijs, Chantal Thys, et al.
Hemasphere|September 29, 2025
Transcriptome profiling of megakaryocytes and platelets: Application to <i>GP9</i>- and <i>IKZF5</i>-related thrombocytopeniaKoenraad De Wispelaere, Fabienne Ver Donck, Kato Ramaekers, et al.
Haematologica|January 14, 2017
The transcription factor GATA1 regulates NBEAL2 expression through a long-distance enhancerAnouck Wijgaerts, Christine Wittevrongel, Chantal Thys, et al.
Nature Medicine|May 31, 2024
Mutations in the U4 snRNA gene RNU4-2 cause one of the most prevalent monogenic neurodevelopmental disordersDaniel Greene, Chantal Thys, Ian R Berry, et al.
Pageof 5